Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Name: Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD
Published: 2023
License: Public Domain

Bial R&D Investments, S.A. · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

neurodegenerative-diseases parkinson-disease parkinson-s-disease

parkinson's disease, parkinson disease, neurodegenerative diseases, central nervous system diseases, glucocerebrosidase (gcase) activity, parkinsonian disorders, basal ganglia diseases, movement disorders, gba1 gene, bia 28-6156, phase 2, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD

Related documents